동물용 첨가제 시장 : 제품 유형, 제제, 동물종, 용도별, 세계 예측(2024-2032년)

Veterinary Excipients Market size is estimated to record over 3.7% CAGR between 2024 and 2032, owing to the increasing need for pharmaceuticals and healthcare products for animals. Rising advancements in veterinary medicine and biotechnology have led to the development of new pharmaceutical formulations, creating increasing demand for high-quality excipients to enhance drug stability, solubility, and bioavailability.

The growing awareness among pet owners regarding the importance of preventive care and the availability of a wide range of veterinary pharmaceuticals has increased the demand for excipients in the formulation of dosage forms, such as tablets, capsules, and solutions. Additionally, the emergence of novel drug delivery technologies and the strong focus on personalized medicine for animals are contributing to the demand for innovative product with specific functionalities. For instance, in February 2024, Loyal, a biotech company that pioneered longevity drugs for dogs, announced the dosage of first dog in its STAY study, the pivotal clinical trial for its drug LOY-002.

The veterinary excipients industry is classified into product type, formulation, animal type, application, and region.

Based on product type, the market size from the fillers and diluents segment will witness 3.8% CAGR in the forecast period. This can be ascribed to their rising assistance in pharmaceutical formulations by improving the physical properties of dosage forms, such as tablet compressibility and powder flowability for enhancing manufacturing efficiency. Moreover, they offer formulation versatility and compatibility with a wide range of active pharmaceutical ingredients (APIs), making them indispensable components in veterinary drug development.

In terms of formulation, the veterinary excipients market from the injectable segment is projected to register strong growth between 2024 and 2032, due to their pivotal role in the administration of pharmaceuticals to animals. They offer rapid onset of action, precise dosage delivery, and improved patient compliance, emerging as preferred choice for veterinary healthcare professionals. As the demand for injectable pharmaceuticals continues to rise, there is a parallel need for excipients to enhance formulation stability, solubility, and safety. Excipients used in injectable formulations also serve critical functions like buffering, tonicity adjustment, and viscosity modification for ensuring the efficacy and safety of veterinary drugs.

Asia Pacific veterinary excipients industry is slated to record 4.3% growth rate during 2024-2032. The rising population of companion animals and livestock is fueling the need for high-quality excipients to support pharmaceutical formulation development. Furthermore, the rapid expansion of the animal health industry in emerging economies, such as China, India, and Southeast Asian countries is presenting significant opportunities for excipient manufacturers and suppliers. Supportive government initiatives aimed at promoting animal health and welfare, coupled with advancements in veterinary medicine and biotechnology, will further stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data validation
• 1.4 Forecast parameters
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in the number of zoonotic diseases
    • 3.2.1.2 Rising awareness about animal health
    • 3.2.1.3 Growing urbanization and industrialization of livestock farming
    • 3.2.1.4 Increasing pet ownership propels veterinary care demand
    • 3.2.1.5 Growing government support on veterinary care
    • 3.2.1.6 Rising R&D and procedural advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of veterinary medicines
    • 3.2.2.2 Lack of access to quality veterinary care in developing economies
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Parent market outlook
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Binders
• 5.3 Disintegrants
• 5.4 Viscosity agents
• 5.5 Fillers and diluents
• 5.6 Flavoring agents
• 5.7 Lubricants and glidants
• 5.8 Emulsifiers
• 5.9 Preservatives
• 5.10 Other product types

Chapter 6 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oral
• 6.3 Injectable
• 6.4 Topical
• 6.5 Other formulations

Chapter 7 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Livestock animals
• 7.3 Companion animals

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Drug formulation
• 8.3 Feed additives
• 8.4 Biologics

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alchemy Impex.
• 10.2 Azelis Group
• 10.3 BASF SE
• 10.4 Clariant
• 10.5 Colorcon
• 10.6 Croda International Plc
• 10.7 Gattefosse Group
• 10.8 IOI Oleo GmbH
• 10.9 JRS Pharma
• 10.10 Lipoid GmbH
• 10.11 Seppic
• 10.12 Synergy API